Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioQuate is a bioprocess technology company specializing in single-use, disposable aseptic connection systems for the biopharmaceutical industry. The company's flagship technology, the Disposable Aseptic Connector (DAC), was developed to simplify and secure the transfer of sterile fluids in non-classified environments, eliminating the need for cleaning and validation. In 2008, GE Healthcare (now Cytiva) acquired the exclusive manufacturing and marketing rights for the DAC technology, integrating it into their ReadyToProcess portfolio as the ReadyMate DAC. BioQuate's innovations have significantly contributed to the adoption of single-use technologies in biomanufacturing by reducing complexity and operational costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioQuate.